These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21895551)

  • 41. Insulin-like growth factor signalling and its significance as a biomarker in fish and shellfish research.
    Chandhini S; Trumboo B; Jose S; Varghese T; Rajesh M; Kumar VJR
    Fish Physiol Biochem; 2021 Aug; 47(4):1011-1031. PubMed ID: 33987811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The insulin-like growth factor system in hematopoietic cells.
    Zumkeller W
    Leuk Lymphoma; 2002 Mar; 43(3):487-91. PubMed ID: 12002750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin-like growth factors in the gastrointestinal tract and liver.
    Kuemmerle JF
    Endocrinol Metab Clin North Am; 2012 Jun; 41(2):409-23, vii. PubMed ID: 22682638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of insulin and insulin-like growth factors on tumor vascularization: new insights of insulin-like growth factor family in cancer.
    Orciari S; Di Nuzzo S; Lazzarini R; Caprari P; Procopio A; Catalano A
    Curr Med Chem; 2009; 16(30):3931-42. PubMed ID: 19747131
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular mechanisms of cognitive impairment in iron deficiency: alterations in brain-derived neurotrophic factor and insulin-like growth factor expression and function in the central nervous system.
    Estrada JA; Contreras I; Pliego-Rivero FB; Otero GA
    Nutr Neurosci; 2014 Sep; 17(5):193-206. PubMed ID: 24074845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin-like growth factors and their receptors in normal physiology and pathological states.
    LeRoith D; Roberts CT
    J Pediatr Endocrinol; 1993; 6(3-4):251-5. PubMed ID: 7920991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin resistance and cancer: the role of insulin and IGFs.
    Djiogue S; Nwabo Kamdje AH; Vecchio L; Kipanyula MJ; Farahna M; Aldebasi Y; Seke Etet PF
    Endocr Relat Cancer; 2013 Feb; 20(1):R1-R17. PubMed ID: 23207292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia.
    Werner H; Le Roith D
    Cell Mol Life Sci; 2000 Jun; 57(6):932-42. PubMed ID: 10950308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin-like growth factor system and sporadic malignant melanoma.
    Capoluongo E
    Am J Pathol; 2011 Jan; 178(1):26-31. PubMed ID: 21224039
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of insulin-like growth factors in steroid modulated proliferation.
    Westley BR; May FE
    J Steroid Biochem Mol Biol; 1994 Oct; 51(1-2):1-9. PubMed ID: 7947343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Receptor tyrosine kinases: mechanisms of activation and signaling.
    Hubbard SR; Miller WT
    Curr Opin Cell Biol; 2007 Apr; 19(2):117-23. PubMed ID: 17306972
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional roles and clinical values of insulin-like growth factor-binding protein-5 in different types of cancers.
    Güllü G; Karabulut S; Akkiprik M
    Chin J Cancer; 2012 Jun; 31(6):266-80. PubMed ID: 22313597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin-like growth factor system regulates oligodendroglial cell behavior: therapeutic potential in CNS.
    Chesik D; De Keyser J; Wilczak N
    J Mol Neurosci; 2008 May; 35(1):81-90. PubMed ID: 18299999
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The insulin-like growth factor system as a treatment target in breast cancer.
    Yee D
    Semin Oncol; 2002 Jun; 29(3 Suppl 11):86-95. PubMed ID: 12138402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The crosstalk between EGF, IGF, and Insulin cell signaling pathways--computational and experimental analysis.
    Zielinski R; Przytycki PF; Zheng J; Zhang D; Przytycka TM; Capala J
    BMC Syst Biol; 2009 Sep; 3():88. PubMed ID: 19732446
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insulin-like growth factor axis targeting in cancer and tumour angiogenesis - the missing link.
    van Beijnum JR; Pieters W; Nowak-Sliwinska P; Griffioen AW
    Biol Rev Camb Philos Soc; 2017 Aug; 92(3):1755-1768. PubMed ID: 27779364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What is the significance of IGF-binding protein-3 proteolysis in the circulation?
    Baxter RC
    J Clin Endocrinol Metab; 2001 Oct; 86(10):5087-8. PubMed ID: 11600591
    [No Abstract]   [Full Text] [Related]  

  • 58. Insulin-like growth factor-related signaling and cancer development.
    Pollak M
    Recent Results Cancer Res; 2007; 174():49-53. PubMed ID: 17302184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel Regulators of the IGF System in Cancer.
    Mancarella C; Morrione A; Scotlandi K
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33673232
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Timing-dependent modulation of insulin mitogenic versus metabolic signalling.
    De Meyts P; Shymko RM
    Novartis Found Symp; 2000; 227():46-57; discussion 57-60. PubMed ID: 10752064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.